Browsing: Wegovy

About our expert: Brian I. Nwannunu, MD, MS, is an orthopedic surgeon with Texas Joint Institute. The medical information in this article is based on an interview with Dr. Nwannunu

GLP-1 weight-loss drugs are not just shedding pounds and trimming waistlines. The popular prescription medications are sweeping through health care, reducing demand for weight-loss operations and improving heart health

Novo Nordisk, a leading Danish pharmaceutical company, has embarked on a late-stage study to identify the minimal effective dose of its obesity drug, Wegovy. This strategic trial aims to retain market share in the competitive obesity sector, projected to be valued at over $100 billion annually by 2030

Amid increasing uptake of GLP-1 weight-loss drugs such as Ozempic and Wegovy, FMCG major Nestlé has realigned its nutritional drinks to meet the changing nutritional needs of users.The company has announced plans to roll out new protein drinks designed for people taking GLP-1 weight-loss medications such as Ozempic and Wegovy in the US, Asia and…

The Pharmacy and Poisons Board (PPB) has approved seven new semaglutide-based medicines in Kenya, expanding treatment options for people living with type 2 diabetes as demand for the drugs continues to rise.

The approval of an oral version of Wegovy in the EU could broaden the impact of GLP-1 medicines on the food and beverage industry, as easier access to weight-management treatment potentially brings more consumers into a market already showing changes in appetite, purchasing behavior, and nutritional priorities

Researchers are increasingly interested in examining the effects of GLP-1 medications beyond weight loss and diabetes management

About our expert: Brian I. Nwannunu, MD, MS, is an orthopedic surgeon with Texas Joint Institute. The medical information in this article is based on an interview with Dr. Nwannunu

On the 9th, Cho Hyun-ah posted recent photos alongside news of Urban Zakapa’s comeback

After the European Commission gave marketing authorisation for the Wegovy semaglutide pill in July, Germany will be the first country to roll it out